Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs ALEMBIC PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES ALEMBIC PHARMA ZYDUS LIFESCIENCES/
ALEMBIC PHARMA
 
P/E (TTM) x 20.7 41.6 49.8% View Chart
P/BV x 2.5 2.2 109.5% View Chart
Dividend Yield % 0.6 1.7 36.2%  

Financials

 ZYDUS LIFESCIENCES   ALEMBIC PHARMA
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-22
ALEMBIC PHARMA
Mar-22
ZYDUS LIFESCIENCES/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs6741,090 61.8%   
Low Rs331672 49.3%   
Sales per share (Unadj.) Rs149.1269.9 55.2%  
Earnings per share (Unadj.) Rs22.726.2 86.6%  
Cash flow per share (Unadj.) Rs29.740.8 72.7%  
Dividends per share (Unadj.) Rs2.5010.00 25.0%  
Avg Dividend yield %0.51.1 43.8%  
Book value per share (Unadj.) Rs166.1266.5 62.3%  
Shares outstanding (eoy) m1,023.74196.56 520.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.43.3 103.2%   
Avg P/E ratio x22.133.6 65.8%  
P/CF ratio (eoy) x16.921.6 78.4%  
Price / Book Value ratio x3.03.3 91.5%  
Dividend payout %11.038.1 28.9%   
Avg Mkt Cap Rs m514,277173,172 297.0%   
No. of employees `000NANA-   
Total wages/salary Rs m21,77711,330 192.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m152,65253,058 287.7%  
Other income Rs m2,354505 466.2%   
Total revenues Rs m155,00653,563 289.4%   
Gross profit Rs m34,4278,741 393.8%  
Depreciation Rs m7,1302,868 248.6%   
Interest Rs m1,270177 716.3%   
Profit before tax Rs m28,3816,201 457.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,1171,045 489.9%   
Profit after tax Rs m23,2645,157 451.2%  
Gross profit margin %22.616.5 136.9%  
Effective tax rate %18.016.8 107.0%   
Net profit margin %15.29.7 156.8%  
BALANCE SHEET DATA
Current assets Rs m122,61429,748 412.2%   
Current liabilities Rs m78,39418,306 428.3%   
Net working cap to sales %29.021.6 134.3%  
Current ratio x1.61.6 96.2%  
Inventory Days Days9311 879.1%  
Debtors Days Days806 1,438.4%  
Net fixed assets Rs m144,38242,554 339.3%   
Share capital Rs m1,024393 260.5%   
"Free" reserves Rs m168,97251,982 325.1%   
Net worth Rs m169,99652,375 324.6%   
Long term debt Rs m3,6210-   
Total assets Rs m266,99672,302 369.3%  
Interest coverage x23.336.0 64.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.7 77.9%   
Return on assets %9.27.4 124.6%  
Return on equity %13.79.8 139.0%  
Return on capital %17.112.2 140.2%  
Exports to sales %043.8 0.0%   
Imports to sales %14.312.7 113.0%   
Exports (fob) Rs mNA23,251 0.0%   
Imports (cif) Rs m21,8696,728 325.1%   
Fx inflow Rs m63,06523,251 271.2%   
Fx outflow Rs m21,8696,728 325.1%   
Net fx Rs m41,19616,523 249.3%   
CASH FLOW
From Operations Rs m21,0415,524 380.9%  
From Investments Rs m11,544-3,720 -310.4%  
From Financial Activity Rs m-8,683-2,174 399.5%  
Net Cashflow Rs m23,729-370 -6,420.2%  

Share Holding

Indian Promoters % 75.0 69.1 108.5%  
Foreign collaborators % 0.0 0.5 -  
Indian inst/Mut Fund % 15.5 17.9 86.9%  
FIIs % 2.6 5.3 48.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 30.4 82.3%  
Shareholders   408,231 103,811 393.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on Cadila Healthcare vs ALEMBIC PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs ALEMBIC PHARMA Share Price Performance

Period Cadila Healthcare ALEMBIC PHARMA S&P BSE HEALTHCARE
1-Day 0.50% 0.91% -0.33%
1-Month -5.33% -2.15% -2.21%
1-Year -10.22% -25.43% -5.83%
3-Year CAGR 16.99% 2.58% 20.87%
5-Year CAGR -0.51% 3.16% 11.42%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the ALEMBIC PHARMA share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of ALEMBIC PHARMA the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of ALEMBIC PHARMA.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of 11.0%.

ALEMBIC PHARMA paid Rs 10.0, and its dividend payout ratio stood at 38.1%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of ALEMBIC PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 320 Points| PolicyBazaar Stake Sale| Oil & Gas and Auto Stocks Witness Most Selling(10:30 am)

Indian share markets opened on a negative note today halting their eight-day rally, amid a weak trend in global markets.